Analysis of thymidine kinase serum levels by novel method DiviTum™ in multiple myeloma and monoclonal gammopathy of undetermined significance - comparison with imaging methods 99mTc-MIBI scintigraphy and 18F-FDG PET/CT
Biomedical Papers of the Faculty of Medicine of Palacky University
Aims. The study aimed at comparing two methods for evaluating thymidinekinase TK in serum -an older RIA method and novel DiviTum™ -in patients with MM and MGUS, and also comparing them with biochemical markers and degree of activity evaluated by imaging methods 99mTc-MIBI scintigraphy and 18F-FDG PET/CT. Methods. Serum thymidinekinase TK levels were evaluated by DiviTum™ and an RIA method (TK REA kit by Immunotech);The study analyzed correlation of TK activity in serum with biochemical markers
... iochemical markers reflecting activity of MM: β2-m, LDH, the ratio of kappa to lambda (κ/λ) free light chains and percentage of bone marrow plasma cells (BMPC). 99mTc-MIBI scintigraphy and 18F-FDG PET/CT were performed at the time of diagnosis. The degree of activity was expressed semiquantitatively. Scans were classified as 0 (normal activity), 1 (diffuse positivity) or 2 (focal positivity). Results. We found a strong positive correlation between TK in serum evaluated by DiviTum™ and by TK REA.. The DiviTum™ analytic method extended the detection range and was able to detect higher levels of TK than the RIA method. DiviTum™ technique found positive correlation with β2-m (r = 0.497) and LDH (r = 0.502) and moderate positive correlation with BMPC (r = 0.368). Significantly higher TK values measured by TK REA and DiviTum™ in the group of patients with MM (stages I, II or III) than in those with MGUS. Increased TK levels were observed in MIBI-or PET/CT-positive patients. Analysis of repeated measurements of TK in serum during treatment of MM patients found a correlation between change in TK measured by DiviTum™ and LDH during treatment. Conclusions. Analysis revealed a significant correlation between TK in serum and LDH, β2-m and BMPC. Increased levels of TK in serum were observed in MIBI-or PET/CT-positive patients. Combination of positivity of imaging methods which can localize active tumor lesions and increased levels of TK in serum can have an impact on decision-making and optimization of the therapeutic approach.